Oncology

Bleomedac

Product Description

Bleomycin is a chemotherapy agent used to treat various malignancies, including head and neck malignancy, lymphoma, and testicular tumors, among others. Bleomycin is a glycopeptide antibiotic with a unique mechanism of antitumor activity. It is well-known to cause s breaks in cellular DNA leading finally to instability of damaged tumor cells. Due to its complicated structure, the production of Bleomycin mainly relies on the microbial fermentation of Streptomyces verticillus.

Active Ingredient

Bleomycin sulphate

Mode of Action

Bleomycin has a cytostatic effect because of its specific binding to DNA, where it causes strand breaks.

After administration, bleomycin forms an active complex with copper (Cu2+) and thus passes through the cell membrane into the cell interior. When the copper splits off in the cell plasma, bleomycin binds to DNA in the nucleus. Activated by free oxygen radicals, it induces strand breaks in the DNA. The greatest susceptibility is shown in cells in the G2 and M phases of the cell cycle.

Indication

  • Squamous cell carcinoma (SCC) of the head and neck, external genitalia and cervix
  • Hodgkin’s lymphoma
  • Non-Hodgkin’s lymphoma of intermediate and high malignancy in adults
  • Testis carcinoma (seminoma and non-seminoma)
  • Intrapleural therapy of malignant pleural effusion

Dosage

Powder for solution for injection:

  • 15000 IU (Ph. Eur.) / 10ml

Not all pack sizes may be marketed.

Materials

Abbreviated product information

Open link External Link

Discover more

Rheumatology

Key rheumatological treatment improved

Rheumatic diseases imply a range of chronic treatment needs across a broad spectrum of patients. With the optimisation of a key treatment in this area, medac has succeeded in bringing a significant improvement to patients' quality of life.

Urology

Addressing unmet needs with urological therapies

Urology is a focus area of highest importance for medac. We have been active in this field from almost the very beginning of our company and are focused on supplying a range of proprietary products that address a variety of unmet therapeutic needs.

Hematology

Innovative and life-saving treatment options

Hematology is a focus area of high importance for medac. To find new treatment approaches for rare diseases, medac addresses critical needs in hematology and has developed innovative products for therapies before and after stem cell transplantation.